Adult congenital heart disease: the challenges of a lifetime

Carole A Warnes1

  • 1Department of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

European Heart Journal
|December 25, 2016
PubMed

Insights

Adults with congenital heart disease (CHD) face lifelong cardiac issues and re-operations. This review explores past, present, and future challenges for both patients and healthcare providers in managing CHD.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease (ACHD) Management
  • Cardiac Surgery

Background:

  • Increasing population of adults with congenital heart disease (CHD).
  • Patients often believe their CHD is fully corrected after initial surgery.
  • Lifelong cardiac problems and re-operation needs present ongoing challenges.

Purpose of the Study:

  • To review the historical, current, and future challenges in managing adults with CHD.
  • To address the complexities faced by medical providers (cardiac surgeons, cardiologists) and patients.
  • To highlight the evolving landscape of ACHD care.

Main Methods:

  • Literature review focusing on adult congenital heart disease.
  • Analysis of challenges across different eras of CHD management.
  • Synthesis of perspectives from healthcare providers and patients.

Main Results:

  • Past challenges included limited understanding and treatment options for CHD.
  • Present challenges involve managing complex adult cases, transitions of care, and re-interventions.
  • Future challenges include optimizing long-term outcomes, addressing emerging comorbidities, and ensuring comprehensive lifelong care.

Conclusions:

  • Effective management of adults with CHD requires a multidisciplinary approach.
  • Continuous adaptation of medical strategies is crucial for improving patient outcomes.
  • Addressing the lifelong needs of the growing ACHD population is paramount for healthcare systems.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
741
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
711
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K